Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| ShiraTronics | 2024 | Series B | $66.0M | Minneapolis |
| Grove Collaborative | 2024 | Post Ipo Equity | $15.0M | San Francisco |
| Intezer | 2024 | Series C | $33.0M | New York |
| Habyt | 2024 | Series Unknown | $44.1M | Berlin |
| MBX Biosciences | 2024 | Series C | $63.5M | Carmel |
| Heeler | 2024 | Seed | $8.5M | Bethesda |
| Courier Health | 2024 | Series A | $16.5M | New York |
| VenoStent | 2024 | Series A | $4.0M | Houston |
| Twisty | 2024 | Pre-Seed | $250K | Los Angeles |
| WEKA | 2024 | Series E | $140.0M | Campbell |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 126 | ShiraTronics | Series B | $66.0M | Minneapolis, United States |
| 127 | Grove Collaborative | Post Ipo Equity | $15.0M | San Francisco, United States |
| 128 | Intezer | Series C | $33.0M | New York, United States |
| 129 | Habyt | Series Unknown | $44.1M | Berlin, Germany |
| 130 | MBX Biosciences | Series C | $63.5M | Carmel, United States |
| 131 | Heeler | Seed | $8.5M | Bethesda, United States |
| 132 | Courier Health | Series A | $16.5M | New York, United States |
| 133 | VenoStent | Series A | $4.0M | Houston, United States |
| 134 | Twisty | Pre-Seed | $250K | Los Angeles, United States |
| 135 | WEKA | Series E | $140.0M | Campbell, United States |
ShiraTronics develops neuromodulation technology to combat debilitating chronic migraine.
Grove creates and curates high-performing, planet-first home, and personal care products.
Intezer is a cybersecurity platform that automates alert triage, incident response, and threat hunting.
Habyt is a housing company that simplifies housing access with digital-first solutions for tenants and landlords.
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Heeler helps security teams scale with developers to eliminate critical risks and reduce future risks for cloud-based applications.
Courier Health is a software company that develops patient engagement platform designed to deliver personalized experiences from end to end.
VenoStent is a tissue engineering medical device company developing bioabsorbable polymer wraps for better outcomes in vascular surgery.
Twisty helps create videos using just text prompts and your imagination.
WEKA is a global data platform company that delivers a cloud-native, software-based data platform for AI & next-generation workloads
ScholarAI is an AI-powered platform designed to enhance academic research efficiency and insights.
Transforming content creation for educators and institutions through advanced AI technology.
Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms.
FloQast is a financial close management software designed to streamline the month-end close process for accounting teams.
Ediphi provides advanced cloud-based estimating solutions on the market.
Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.
Healthcare information today is produced from a large variety of sources
Turso is an open-source Edge database that brings the developer experience of SQLite closer to the users.
Prevedere is a provider of predictive analytics technology and solutions based on econometric modeling.
Xpressbees is a logistics company that offers customized express delivery services.
Lyra Collective is a multi-brand company offering personal care and family products for daily wellness and routines.
Mensa Brands is a direct-to-consumer company that partners with entrepreneurs to build and scale digital brands.
Boost’s API-driven infrastructure makes it easy for any company to increase customer value by offering embedded insurance.
MotherDuck provides data infrastructure and analytics for both small and big data.
HighFive Healthcare optimize dental practices by centralizing operations, leveraging technology to reduce costs associated with dental care.
Norwest has invested in 230 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Norwest's top investment sectors include Health Care, Software, Artificial Intelligence (AI), E-Commerce, Information Technology. The firm invests across 55 different industry categories.
Among tracked funding rounds, Engrail Therapeutics received $157.0M in a Series B round. Norwest's total known invested capital is $6.5B.
Norwest's average investment size is $53.9M across its portfolio of 230 companies.
Recent Norwest portfolio additions include ShiraTronics, Grove Collaborative, Intezer, Habyt, MBX Biosciences. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors